PubMed:11087743
Annnotations
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 59-66 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T3 | 401-408 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T5 | 1055-1062 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T7 | 1198-1205 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T9 | 1592-1599 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T11 | 1601-1608 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T13 | 1860-1867 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T15 | 2012-2019 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-75 | Sentence | denotes | Characterization of the stromal cell-derived factor-1alpha-heparin complex. |
| T2 | 76-181 | Sentence | denotes | The binding of chemokines to glycosaminoglycans is thought to play a crucial role in chemokine functions. |
| T3 | 182-480 | Sentence | denotes | It has recently been shown that stromal cell-derived factor-1alpha (SDF-1alpha), a CXC chemokine with potent anti-human immunodeficiency virus activity, binds to heparan sulfate through a typical consensus sequence for heparin recognition (BBXB, where B is a basic residue KHLK, amino acids 24-27). |
| T4 | 481-769 | Sentence | denotes | Calculation of the accessible surface, together with the electrostatic potential of the SDF-1alpha dimer, revealed that other amino acids (Arg-41 and Lys-43) are found in the same surface area and contribute to the creation of a positively charged crevice, located at the dimer interface. |
| T5 | 770-905 | Sentence | denotes | GRID calculations confirmed that this binding site will be the most energetically favored area for the interaction with sulfate groups. |
| T6 | 906-1063 | Sentence | denotes | Site-directed mutagenesis and surface plasmon resonance-based binding assays were used to investigate the structural basis for SDF-1alpha binding to heparin. |
| T7 | 1064-1206 | Sentence | denotes | Among the residues clustered in this basic surface area, Lys-24 and Lys-27 have dominant roles and are essential for interaction with heparin. |
| T8 | 1207-1328 | Sentence | denotes | Amino acids Arg-41 and Lys-43 participate in the binding but are not strictly required for the interaction to take place. |
| T9 | 1329-1547 | Sentence | denotes | Direct binding assays and competition analysis with monoclonal antibodies also permitted us to show that the N-terminal residue (Lys-1), an amino acid critical for receptor activation, is involved in complex formation. |
| T10 | 1548-1846 | Sentence | denotes | Binding studies with selectively desulfated heparin, heparin oligosaccharides, and heparitinase-resistant heparan sulfate fragments showed that a minimum size of 12-14 monosaccharide units is required for efficient binding and that 2-O- and N-sulfate groups have a dominant role in the interaction. |
| T11 | 1847-1971 | Sentence | denotes | Finally, the heparin-binding site was identified on the crystal structure of SDF-1alpha, and a docking study was undertaken. |
| T12 | 1972-2091 | Sentence | denotes | During the energy minimization process, heparin lost its perfect ribbon shape and fitted the protein surface perfectly. |
| T13 | 2092-2249 | Sentence | denotes | In the model, Lys-1, Lys-24, Lys-27, and Arg-41 were found to have the major role in binding a polysaccharide fragment consisting of 13 monosaccharide units. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 59-66 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 59-66 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T3 | 401-408 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T4 | 401-408 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T5 | 1055-1062 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T6 | 1055-1062 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T7 | 1198-1205 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T8 | 1198-1205 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T9 | 1592-1599 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T10 | 1592-1599 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T11 | 1601-1608 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T12 | 1601-1608 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T13 | 1860-1867 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T14 | 1860-1867 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T15 | 2012-2019 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T16 | 2012-2019 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 344-359 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
| T2 | 1654-1669 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
Ab3P-abbreviations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SF0 | 250-260 | ABBR | denotes | SDF-1alpha |
| LF0 | 214-248 | ABBR | denotes | stromal cell-derived factor-1alpha |
| R0 | LF0 | SF0 | ShortForm | stromal cell-derived factor-1alpha,SDF-1alpha |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 302-318 | Disease | denotes | immunodeficiency | http://purl.obolibrary.org/obo/MONDO_0021094 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 302-318 | Phenotype | denotes | immunodeficiency | HP:0002721 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 302-318 | Phenotype | denotes | immunodeficiency | HP:0002721 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-75 | Sentence | denotes | Characterization of the stromal cell-derived factor-1alpha-heparin complex. |
| T2 | 76-181 | Sentence | denotes | The binding of chemokines to glycosaminoglycans is thought to play a crucial role in chemokine functions. |
| T3 | 182-480 | Sentence | denotes | It has recently been shown that stromal cell-derived factor-1alpha (SDF-1alpha), a CXC chemokine with potent anti-human immunodeficiency virus activity, binds to heparan sulfate through a typical consensus sequence for heparin recognition (BBXB, where B is a basic residue KHLK, amino acids 24-27). |
| T4 | 481-769 | Sentence | denotes | Calculation of the accessible surface, together with the electrostatic potential of the SDF-1alpha dimer, revealed that other amino acids (Arg-41 and Lys-43) are found in the same surface area and contribute to the creation of a positively charged crevice, located at the dimer interface. |
| T5 | 770-905 | Sentence | denotes | GRID calculations confirmed that this binding site will be the most energetically favored area for the interaction with sulfate groups. |
| T6 | 906-1063 | Sentence | denotes | Site-directed mutagenesis and surface plasmon resonance-based binding assays were used to investigate the structural basis for SDF-1alpha binding to heparin. |
| T7 | 1064-1206 | Sentence | denotes | Among the residues clustered in this basic surface area, Lys-24 and Lys-27 have dominant roles and are essential for interaction with heparin. |
| T8 | 1207-1328 | Sentence | denotes | Amino acids Arg-41 and Lys-43 participate in the binding but are not strictly required for the interaction to take place. |
| T9 | 1329-1547 | Sentence | denotes | Direct binding assays and competition analysis with monoclonal antibodies also permitted us to show that the N-terminal residue (Lys-1), an amino acid critical for receptor activation, is involved in complex formation. |
| T10 | 1548-1846 | Sentence | denotes | Binding studies with selectively desulfated heparin, heparin oligosaccharides, and heparitinase-resistant heparan sulfate fragments showed that a minimum size of 12-14 monosaccharide units is required for efficient binding and that 2-O- and N-sulfate groups have a dominant role in the interaction. |
| T11 | 1847-1971 | Sentence | denotes | Finally, the heparin-binding site was identified on the crystal structure of SDF-1alpha, and a docking study was undertaken. |
| T12 | 1972-2091 | Sentence | denotes | During the energy minimization process, heparin lost its perfect ribbon shape and fitted the protein surface perfectly. |
| T13 | 2092-2249 | Sentence | denotes | In the model, Lys-1, Lys-24, Lys-27, and Arg-41 were found to have the major role in binding a polysaccharide fragment consisting of 13 monosaccharide units. |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 302-318 | Disease | denotes | immunodeficiency | MONDO:0021094 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 296-301 | Organism | denotes | human | 9606 |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 344-359 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
| T2 | 1654-1669 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 24-36 | Body_part | denotes | stromal cell | http://purl.obolibrary.org/obo/CL_0000499 |
| T2 | 214-226 | Body_part | denotes | stromal cell | http://purl.obolibrary.org/obo/CL_0000499 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 296-301 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 24-36 | Body_part | denotes | stromal cell | http://purl.obolibrary.org/obo/CL_0000499 |
| T2 | 214-226 | Body_part | denotes | stromal cell | http://purl.obolibrary.org/obo/CL_0000499 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 24-36 | Cell | denotes | stromal cell | http://purl.obolibrary.org/obo/CL:0000499 |
| T2 | 214-226 | Cell | denotes | stromal cell | http://purl.obolibrary.org/obo/CL:0000499 |